Kymera Perspectives
Hear from our team on recent breakthroughs, scientific and clinical advancements, company culture, and our ongoing work to develop new medicines at Kymera.
September 10, 2026
When Sagar Agarwal joined Kymera, the clinical pharmacology playbook for degraders had yet to be written. Five years later, he reflects on the pioneering science he helped advance, the frameworks and team he helped build, and why charting new territory is central to what it means to be a Kymerian.
Featured
December 16, 2025
From Target Selection to POC in Patients: Completing the Initial Human Translation of STAT6 Degradation
Nello Mainolfi, PhD, Founder, President and CEO
April 15, 2026
A Conversation with Kymera’s Chief Business Officer, Noah Goodman
Noah Goodman, MBA, Chief Business Officer
April 24, 2025
A New Era of Possibility: Addressing Coveted Undrugged Targets
Juliet Williams, PhD, Head of Research
Discover Our Latest Milestones
Stay ahead with the latest news from Kymera. Our Press Releases provide insights into our recent achievements and future endeavors.
Related Stories
